| Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. RL White, DS Burgess, M Manduru, JA Bosso Antimicrobial agents and chemotherapy 40 (8), 1914-1918, 1996 | 862 | 1996 |
| Extended‐spectrum β‐lactamases: epidemiology, detection, and treatment S Nathisuwan, DS Burgess, JS Lewis Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (8 …, 2001 | 367 | 2001 |
| Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports GC Lee, DS Burgess Annals of clinical microbiology and antimicrobials 11, 1-9, 2012 | 281 | 2012 |
| Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance DS Burgess Chest 115 (3), 19S-23S, 1999 | 203 | 1999 |
| Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia CR Frei, MI Restrepo, EM Mortensen, DS Burgess The American journal of medicine 119 (10), 865-871, 2006 | 174 | 2006 |
| Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation CR Frei, NP Wiederhold, DS Burgess Journal of antimicrobial chemotherapy 61 (3), 621-628, 2008 | 144 | 2008 |
| Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit CR Frei, RT Attridge, EM Mortensen, MI Restrepo, Y Yu, ... Clinical therapeutics 32 (2), 293-299, 2010 | 138 | 2010 |
| Single dose and multiple dose studies of itraconazole nanoparticles JM Vaughn, JT McConville, D Burgess, JI Peters, KP Johnston, RL Talbert, ... European journal of pharmaceutics and biopharmaceutics 63 (2), 95-102, 2006 | 132 | 2006 |
| Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy 61 (2), e02089-16, 2017 | 113 | 2017 |
| Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model JT McConville, KA Overhoff, P Sinswat, JM Vaughn, BL Frei, DS Burgess, ... Pharmaceutical research 23 (5), 901-911, 2006 | 105 | 2006 |
| Clinical and microbiologic analysis of a hospital's extended‐spectrum β‐lactamase‐producing isolates over a 2‐year period DS Burgess, RG Hall, JS Lewis, JH Jorgensen, JE Patterson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (10 …, 2003 | 101 | 2003 |
| Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation CP Martin, RL Talbert, DS Burgess, JI Peters Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (1 …, 2007 | 93 | 2007 |
| Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing DS Burgess, T Waldrep Clinical therapeutics 24 (7), 1090-1104, 2002 | 89 | 2002 |
| Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia DS Burgess, JS Lewis II Clinical therapeutics 22 (7), 872-878, 2000 | 89 | 2000 |
| Use of Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Treatment of Pseudomonas aeruginosa Infections DS Burgess Clinical infectious diseases 40 (Supplement_2), S99-S104, 2005 | 88 | 2005 |
| Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion DS Burgess, RW Hastings, TC Hardin Clinical therapeutics 22 (1), 66-75, 2000 | 86 | 2000 |
| Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin JM Cota, JL Grabinski, RL Talbert, DS Burgess, PD Rogers, TD Edlind, ... Antimicrobial agents and chemotherapy 52 (3), 1144-1146, 2008 | 81 | 2008 |
| In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae DS Burgess, RG Hall II Diagnostic microbiology and infectious disease 49 (1), 41-46, 2004 | 81 | 2004 |
| Acute kidney injury in patients treated with vancomycin and piperacillin‐tazobactam: a retrospective cohort analysis WC Rutter, DR Burgess, JC Talbert, DS Burgess Journal of hospital medicine 12 (2), 77-82, 2017 | 78 | 2017 |
| Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa DS Burgess, S Nathisuwan Diagnostic microbiology and infectious disease 44 (1), 35-41, 2002 | 78 | 2002 |
